Charles River Laboratories International Inc (MEX:CRL)
MXN 3917.07 0 (0%) Market Cap: 200.20 Bil Enterprise Value: 250.74 Bil PE Ratio: 24.84 PB Ratio: 2.99 GF Score: 71/100

Charles River Laboratories International Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 03:20PM GMT
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. There we go. And we're live. Hi everybody, Luke Sergott from Barclays. I cover Life Science Diagnostics & Tools here. It's my pleasure to have Jim Foster from Charles River Labs. About a seasoned veteran in the space as they come, and a transparent and clear message can be provided. So if you want to take over and provide a couple of sentences or introduction, then I'll just dive into questions.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Great. Thanks, Luke. Nice to be here. Just by way of quick background. We ended fiscal '20 very strong with 7% growth rate in a COVID world, which we were extremely pleased with. We did -- we acquired 2 cell product companies with cellular therapy, research and development during the year. We ended the year with the acquisition of a large molecule discovery platform, which was one of our technology deals that we just announced a couple of weeks ago now, I think, that we signed, but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot